Understand the source comparison
5-Amino-1MQ vs AOD-9604: Head-to-Head Comparison
Before making a peptide selection for your research protocol, understanding the mechanistic and practical differences between 5-Amino-1MQ and AOD-9604 determines experimental validity and result interpretation. Primary Mechanism NNMT inhibition → NAD+ restorat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before making a peptide selection for your research protocol, understanding the mechanistic and practical differences between 5-Amino-1MQ and AOD-9604 determines experimental validity and result interpretation.
- Primary Mechanism
- NNMT inhibition → NAD+ restoration → AMPK activation → fat oxidation
- Direct adipocyte beta-3 receptor agonism → hormone-sensitive lipase activation → lipolysis
- 5-Amino-1MQ = systemic metabolic shift; AOD-9604 = isolated lipolytic effect
- Upstream vs Downstream
- Acts upstream at enzyme level (NNMT)
- Acts downstream at receptor level (adipocyte surface)
- 5-Amino-1MQ affects broader metabolic pathways; AOD-9604 targets fat cells specifically
- Effect on Insulin Sensitivity
- Improves insulin sensitivity via AMPK activation (demonstrated in murine models)
- Neutral. No effect on insulin signaling pathways
- 5-Amino-1MQ useful for insulin resistance models; AOD-9604 cleaner for glucose-independent studies
- Human Clinical Data
- Limited to small pilot cohorts; no Phase 2/3 trials as of 2026
- Phase 2 completed (300+ participants, 12 weeks); failed FDA approval for efficacy, not safety
- AOD-9604 has more human exposure data but lacked sufficient efficacy for approval
- Typical Research Dosing
- 50–100 mg oral daily in murine studies; human equivalent ~5–10 mg/kg extrapolated
- 0.5–1.0 mg subcutaneous injection daily in clinical trials
- Dosing not directly comparable due to different routes and mechanisms
- Best Research Fit
- Metabolic syndrome models, NAD+ dynamics, mitochondrial dysfunction, NAFLD
- Adipocyte lipolysis, body composition studies, growth hormone research without IGF-1 confounds
- Choose based on whether systemic metabolism or isolated fat mobilization is the experimental target